Recruiting Myelofibrosis Studies in Ann Arbor
About Myelofibrosis Clinical Trials in Ann Arbor
Myelofibrosis is a serious bone marrow disorder that disrupts normal blood cell production, leading to extensive scarring in the bone marrow. It can cause severe anemia, weakness, and an enlarged spleen. Treatment includes JAK inhibitors, blood transfusions, and stem cell transplant.
There are currently 1 myelofibrosis clinical trials recruiting participants in Ann Arbor, MICHIGAN. These studies are seeking a combined 150 participants. Research is being sponsored by Disc Medicine, Inc. Clinical trial participation is free and participants receive study-related medical care at no cost.
Myelofibrosis Clinical Trials in Ann Arbor — FAQ
Are there myelofibrosis clinical trials in Ann Arbor?
Yes, there are 1 myelofibrosis clinical trials currently recruiting in Ann Arbor, MICHIGAN. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Ann Arbor?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Ann Arbor research site will contact you about next steps.
Are clinical trials in Ann Arbor free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Ann Arbor studies also compensate for your time and travel.
What myelofibrosis treatments are being tested?
The 1 active trials in Ann Arbor are testing new therapies including novel drugs, biologics, and treatment approaches for myelofibrosis.
Data updated March 2, 2026 from ClinicalTrials.gov